Adjuvant Intravesical Chemohyperthermia Versus Passive Chemotherapy in Patients with Intermediate-risk Non–muscle-invasive Bladder Cancer (HIVEC-II): A Phase 2, Open-label, Randomised Controlled Trial-Reference-Cited by-同舟云学术

Adjuvant Intravesical Chemohyperthermia Versus Passive Chemotherapy in Patients with Intermediate-risk Non–muscle-invasive Bladder Cancer (HIVEC-II): A Phase 2, Open-label, Randomised Controlled Trial

Published:2022-08 Issue: Volume: Page:
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Tan Wei Shen,Prendergast Aaron,Ackerman Charlotte,Yogeswaran Yathushan,Cresswell Joanne,Mariappan Paramananthan,Phull Jaspal,Hunter-Campbell Paul,Lazarowicz Henry,Mishra Vibhash,Rane Abhay,Davies Melissa,Warburton Hazel,Cooke Peter,Mostafid Hugh,Wilby Daniel,Mills Robert,Issa Rami,Kelly John D.

Publisher

Elsevier BV

Subject

Urology

Reference27 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

2. Epidemiology of bladder cancer: a systematic review and contemporary update of risk factors in 2018;Cumberbatch;Eur Urol,2018

3. European Association of Urology guidelines on non–muscle-invasive bladder cancer (Ta, T1, and carcinoma in situ);Babjuk;Eur Urol,2022

4. Tan WS, Steinberg G, Witjes JA, et al. Intermediate-risk non–muscle-invasive bladder cancer: updated consensus definition and management recommendations from the International Bladder Cancer Group. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2022.05.005.

5. Management of non-muscle invasive bladder cancer: a comprehensive analysis of guidelines from the United States;Tan;Europe and Asia. Cancer Treat Rev,2016

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. De-Escalation of Therapy for Low-Grade Papillary Bladder Tumors With Preserved Long-Term Oncologic Outcomes;Urology Practice;2024-09

2. Efficacy of conduction hyperthermia in the treatment of non-muscle invasive bladder cancer: A systematic review;Urologic Oncology: Seminars and Original Investigations;2024-09

3. Treatment Strategies for BCG Unresponsive Non-muscle Invasive Bladder Cancer;annals of urologic oncology;2024-08-29

4. European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ)—A Summary of the 2024 Guidelines Update;European Urology;2024-08

5. Harnessing Bacterial Membrane Components for Tumor Vaccines: Strategies and Perspectives;Advanced Healthcare Materials;2024-07-04